NK:IO logo
NK:IO logo

NK:IO

nk-io.com
nk-io.com • Seed 2023 • Startup • New
Seed 2023 • Startup • New
Actively hiring
As featured in
NewsMedical
Benzinga
Technology Networks
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$1.5M
1 round on record
Latest round
$1.5M
Seed · Jul 2023 · 3 yr ago
Backers
2
Cambridge Angels, Future Planet Capital
The money's age
Long since its last round
38 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Funding rounds
RoundDateAmountInvestorsSource
Seed Jul 2023 $1.5M — benzinga.com
Backed byfrom the funds' portfolios and accelerator catalogs
Cambridge Angels fund Future Planet Capital fund
Similar startupsby what they do, their industry and backers
IMU Biosciences3 roles
Unlocking the potential of the immune system. IMU.
BugBiome
At BugBiome, our mission is to create safer pest control solutions by harnessing natural microbiomes through our high-throughput screening…
Brenig Therapeutics, Inc.Founded 2021
Brenig Therapeutics develops innovative small-molecule therapies for neurodegenerative diseases, including LRRK2 inhibitors targeting…
Therini BioVenture round $74.9M · 3 yr ago • Founded 2016 • 51-200 employees
Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.
AtelerixFounded 2017
Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell…
Pheast Therapeutics
At Pheast Therapeutics, we are developing new innate immune checkpoint inhibitors, including anti-CD24, to unleash the power of macrophages…

Overview

By harnessing the potential of the innate immune system, we are developing ground breaking NK cell and small molecule therapies. Learn More at NK:IO.

News

News NewsMedical 3 years ago
NK:IO raises £1.2M, bringing total Seed funding to £5.1M, to advance pioneering NK cell therapy
New investment of £1.2M brings total Seed funding to £5.1M including Innovate UK grants of £1.9M.
Read more
Report
Press release 3 years ago
NK:IO raises £1.2M, bringing total Seed funding to £5.1M, to advance pioneering NK cell therapy
NK:IO raises £1.2M, bringing total Seed funding to £5.1M, to advance pioneering NK cell therapy.
Read more
Report
Press release benzinga.com 3 years ago
NK:IO Raises £1.2M, Bringing Total Seed Funding to £5.1M, to Advance Pioneering NK Cell Therapy Read more
Report
Award technologynetworks.com 3 years ago
Nk:io Awarded £1.6M Innovate UK New Cancer Therapeutics Grant for Development of Nk Cell Therapy Read more
Report
Award 3 years ago
Imperial spinout NK:IO awarded £1.6M Innovate UK New Cancer Therapeutics grant for development of pioneering NK cell therapy
Grant award of £1.6M supports program of development work with Cell and Gene Therapy Catapult NK:IO's platform, based on pioneering discoveries in NK cell biology, yields industry-leading tumour killing and cell production London, UK, 11 July 2023: NK:IO,
Read more
Report
Pro access
Upgrade to see all 7 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.

Financials

Total raised
$1.5M
Latest round
Seed
Funding rounds
1
Funding rounds
Round Announced Amount
Seed 2023 $1.5M Details